QX600 Droplet Digital PCR System

Droplet Digital™ PCR (ddPCR™) technology has advanced the absolute quantification of nucleic acids, becoming a reliable tool for clinical and translational research. Examine the application of ddPCR for DNA methylation detection, and explore workflow strategies, and key parameters for achieving sensitivity, linearity, and reproducibility in assay design.

Ultra-sensitive tools for molecular detection continue to improve our ability to detect clinical responses to treatments more rapidly, measure therapeutic effect in drug trials more effectively, and alert doctors of pending cancer relapse much earlier than is possible with standard techniques. Explore the applications of ddPCR™ Technology in solid tumor oncology, in this resource from Bio-Rad.

From an initial cancer diagnosis to tracking response to therapy, discover how the inherent benefits of droplet digital PCR (ddPCR) make it an ideal technology for screening mutations such as SNPs, structural variants, methylation changes, and more in this free infographic.

In this infographic, Bio-Rad provides a brief history of RNA-based therapy and outlines how Bio-Rad™ Droplet Digital™ PCR (ddPCR™) technology supports this field of work.

The use of RNA as a therapeutic to effect clinically meaningful targets is an exciting new area of work with huge potential.

In this infographic, Bio-Rad provides an overview of how RNA can be used in a therapeutic application, some of the challenges associated with this new field, and how Droplet Digital™ PCR (ddPCR™) technology is helping address some of these challenges to fuel the RNA therapeutics revolution.

Droplet DigitalTM PCR (ddPCRTM ) technology is a wastewater surveillance approach that offers sensitivity and quantification for the detection of outbreaks and specific variants of SARS-CoV-2 in communities

Droplet Digital PCR (ddPCR) is a method for performing digital PCR that is based on water-oil emulsion droplet technology.

The QX600 Droplet Digital PCR System (ddPCR™) offers advanced six-color multiplexing and absolute quantification of nucleic acid.

Monday, October 27, at 15:00 GMT | 16:00 CET | 11:00 EDT | 8:00 PDT

This webinar will explore the insights from the ddPCR World on Tour event in London and introduce the next evolution of Droplet Digital™ PCR (ddPCR™) technology. You’ll hear directly from fellow researchers and pioneers in the field as they share how ddPCR has advanced their studies, from detecting rare mutations to improving transplant monitoring. Plus, discover how Bio-Rad’s latest systems deliver exceptional sensitivity, simplicity, and performance, enabling absolute quantification, scalable workflows, and reliable results with minimal sample input.

Key learning objectives:

• Explore the latest ddPCR innovations and how they improve sensitivity, reproducibility, and ease of use.
• Hear about practical applications of ddPCR, from rare mutation detection to transplant monitoring.
• Gain real-world insights through user testimonials on how ddPCR has advanced their research.

The session will conclude with a Q&A, giving you the chance to ask our experts questions directly and gain practical insights to apply to your own research. Don’t miss this opportunity to see how ddPCR can transform your experiments.

Certificate of attendance

If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.

Discover how Droplet Digital™ PCR is advancing precision monitoring in oncology through Development of a Highly Sensitive and Specific Droplet Digital PCR Assay for Multiplexed Detection and Longitudinal Monitoring of ESR1 Variants in Plasma: A QX600 Case Study, presented by Leisa Jackson, Scientist at Biodesix, and recorded earlier this year at ddPCR™ World.

The following presentation is part of a Bio-Rad hosted event for Droplet Digital PCR (ddPCR) research applications. The products are intended for research use only and are not intended for use in diagnostic procedures. Any clinical applications, test validations, or performance claims discussed are the sole responsibility of the presenting institution or speaker and do not reflect the views or endorsements of Bio-Rad Laboratories.

Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital PCR technology

Pioneering research into ddPCR technology by two leading scientists is advancing research in oncology

Bio-Rad outlines strategic collaborations to enable clinical evidence generation and advance precision oncology

With the help of Bio-Rad’s ultra-sensitive, multiplexed digital PCR system, Biodesix and its research partners are pursuing novel blood tests for the early detection and targeted treatment of lung cancer

Explore the versatile role of ddPCR technology in immuno-oncology for precise and sensitive nucleic acid quantification